{"news_desk": "Editorial", "print_page": null, "subsection_name": null, "section_name": "Opinion", "byline": {"original": "By VIKAS BAJAJ", "person": [{"firstname": "Vikas", "rank": 1, "lastname": "BAJAJ", "organization": "", "role": "reported"}]}, "abstract": null, "type_of_material": "Editorial", "word_count": "700", "keywords": [{"rank": "1", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "name": "subject"}, {"rank": "2", "value": "Health Insurance and Managed Care", "is_major": "N", "name": "subject"}], "lead_paragraph": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline.", "pub_date": "2016-10-21T17:03:25+0000", "document_type": "article", "source": "The New York Times", "snippet": "Companies can drop prices and still make money, says the chief executive of GlaxoSmithKline....", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbWide.jpg"}, {"height": 400, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/10/21/opinion/21bajajWEB/21bajajWEB-thumbStandard.jpg"}], "web_url": "http://www.nytimes.com/2016/10/21/opinion/the-pharma-ceo-who-wants-to-lower-drug-prices.html", "slideshow_credits": null, "blog": [], "_id": "580a4a6495d0e022439c4868", "headline": {"main": "The Pharma C.E.O. Who Wants to Lower Drug Prices", "content_kicker": "Taking Note", "kicker": "Taking Note"}}